<DOC>
	<DOCNO>NCT00062777</DOCNO>
	<brief_summary>Since 1948 , resident Framingham , Massachusetts , participate program collect blood sample clinical data provide rare valuable database scientific research . The purpose study support national resource aid research capacity . Specifically , researcher study ( 1 ) investigate heart , lung , blood disease ; stroke ; memory loss ; joint disease ; bone loss ; deafness ; cancer ; blood vessel diseases health condition , ( 2 ) examine DNA relationship risk develop disease health condition . Approximately 330 family participate Framingham Study . Participants require undergo four-hour exam take exam every two year thereafter . During exam , Framingham investigator ( 1 ) interview participant medical status , health issue , lifestyle ; ( 2 ) perform regular physical exam ; ( 3 ) obtain blood urine sample administer glucose-tolerance test ; ( 4 ) supervise brisk six-minute treadmill walk ; ( 5 ) administer ultrasound procedure ; ( 6 ) review obtain copy medical hospital record . Participants also ask complete questionnaire home regard dietary health habit .</brief_summary>
	<brief_title>The Framingham Study : Examining DNA Markers Links Diseases</brief_title>
	<detailed_description>Many study show hematocrit ( HCT ) level associate cerebrovascular disease , cardiovascular disease ( CVD ) , peripheral vascular disease , well all-cause mortality . Twin study show HCT variation largely determined genetic factor heritability estimate 40 % - 65 % . So far , linkage analysis human HCT DNA marker report . The purpose protocol identify chromosome region contain quantitative trait locus ( QTL ) involve control HCT level . In Framingham Study , 10cM genome scan ( 400 marker ) conduct 330 family . HCT measure original cohort Framingham offspring . These data provide u opportunity undertake linkage analysis use variance component method map quantitative trait locus ( QTL ) HCT .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>INCLUSION /EXCLUSION CRITERIA The study population include member 330 Framingham Study family genome scan .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 16, 2011</verification_date>
	<keyword>Genetics</keyword>
	<keyword>Populations</keyword>
	<keyword>CVD Risk</keyword>
	<keyword>Gene Mapping</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Framingham Study</keyword>
	<keyword>Vascular Diseases</keyword>
</DOC>